# Electromechanical Mapping to Evaluate Heart Muscle

> **NCT00001895** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 71 (—)

## Conditions studied

- Myocardial Ischemia

## Interventions

- **DRUG:** FDG
- **DRUG:** NH(3)

## Key facts

- **NCT ID:** NCT00001895
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** —
- **Final completion:** 2001-12
- **Target enrollment:** 71 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001895, "Electromechanical Mapping to Evaluate Heart Muscle". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00001895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*